Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Traws Pharma (TRAW) Revenue (2016 - 2025)

Historic Revenue for Traws Pharma (TRAW) over the last 14 years, with Q2 2025 value amounting to $2.7 million.

  • Traws Pharma's Revenue rose 469473.68% to $2.7 million in Q2 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 115929.2%. This contributed to the annual value of $226000.0 for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q2 2025, Traws Pharma's Revenue is $2.7 million, which was up 469473.68% from $57000.0 recorded in Q1 2025.
  • Traws Pharma's Revenue's 5-year high stood at $2.7 million during Q2 2025, with a 5-year trough of $56000.0 in Q1 2021.
  • In the last 5 years, Traws Pharma's Revenue had a median value of $57000.0 in 2021 and averaged $205222.2.
  • As far as peak fluctuations go, Traws Pharma's Revenue crashed by 1363.64% in 2021, and later soared by 469473.68% in 2025.
  • Quarter analysis of 5 years shows Traws Pharma's Revenue stood at $56000.0 in 2021, then changed by 0.0% to $56000.0 in 2022, then changed by 0.0% to $56000.0 in 2023, then changed by 0.0% to $56000.0 in 2024, then skyrocketed by 4780.36% to $2.7 million in 2025.
  • Its Revenue was $2.7 million in Q2 2025, compared to $57000.0 in Q1 2025 and $56000.0 in Q4 2024.